Cargando…

Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.

Detalles Bibliográficos
Autores principales:	Harwood, P. J., Pedley, R. B., Boden, J., Rawlins, G., Pentycross, C. R., Rogers, G. T., Bagshawe, K. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1985
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977225/ https://www.ncbi.nlm.nih.gov/pubmed/2998427

Ejemplares similares

Dose-dependent localisation and potential for therapy of F(ab')2 fragments against CEA studied in a human tumour xenograft model.
por: Rogers, G. T., et al.
Publicado: (1986)

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989)

Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.
por: Sharma, S. K., et al.
Publicado: (1990)

The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
por: Pedley, R. B., et al.
Publicado: (1994)

Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serum.
por: Rogers, G. T., et al.
Publicado: (1981)

Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
por: Boxer, G. M., et al.
Publicado: (1994)

Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
por: Pedley, R. B., et al.
Publicado: (1993)

Somatic-cell hybrids producing antibodies against CEA.
por: Rogers, G. T., et al.
Publicado: (1981)

Relationship of serum CEA levels to tumour size and CEA content in nude mice bearing colonic-tumour xenografts.
por: Lewis, J. C., et al.
Publicado: (1981)

Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.
por: Pedley, R. B., et al.
Publicado: (1990)

Fractionated (131)I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice
por: Violet, J A, et al.
Publicado: (2008)

Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
por: Allum, W. H., et al.
Publicado: (1986)

The potential of carboxypeptidase G2: antibody conjugates as anti-tumour agents. II. In vivo localising and clearance properties in a choriocarcinoma model.
por: Melton, R. G., et al.
Publicado: (1990)

A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.
por: Bagshawe, K. D., et al.
Publicado: (1987)

An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts.
por: Pimm, M. V.
Publicado: (1990)

Extraction of CEA from tumour tissue, foetal colon and patients' sera, and the effect of perchloric acid.
por: Keep, P. A., et al.
Publicado: (1978)

Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.
por: Ford, C. H., et al.
Publicado: (1983)

Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.
por: Marshall, D., et al.
Publicado: (1994)

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.
por: Hird, V., et al.
Publicado: (1991)

Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
por: Bruland, O., et al.
Publicado: (1987)

Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.
por: Quayle, J. B.
Publicado: (1982)

Comments on “The SCM Test for Cancer. An Evaluation in Terms of Lymphocytes from Healthy Donors and Cancer Patients”
por: Bagshawe, K. D., et al.
Publicado: (1980)

Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer.
por: Ornadel, D., et al.
Publicado: (1998)

A human choriocarcinoma xenograft in nude mice; a model for the study of antibody localization.
por: Searle, F., et al.
Publicado: (1981)

The site of binding of anti-CEA antibodies to tumour CEA in vivo: an immunocytochemical and autoradiographic approach.
por: Moshakis, V., et al.
Publicado: (1982)

Serial cytogenetic studies of human colonic tumour xenografts.
por: Reeves, B. R., et al.
Publicado: (1978)

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA
por: Watson, S A, et al.
Publicado: (1999)

Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies.
por: Price, M. R.
Publicado: (1988)

Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.
por: Boxer, G. M., et al.
Publicado: (1992)

Carcinoembryonic antigen (CEA) expression and heterogeneity in primary and autologous metastatic gastric tumours demonstrated by a monoclonal antibody.
por: Hockey, M. S., et al.
Publicado: (1984)

Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.
por: Marshall, D., et al.
Publicado: (1995)

Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits.
por: Ledermann, J. A., et al.
Publicado: (1988)

Selective Radionuclide Localisation in Primary Liver Tumours
por: Novell, J. R., et al.
Publicado: (1994)

Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method
por: Schoffelen, Rafke, et al.
Publicado: (2012)

Thermo-stability and antitumor activity on colon cancer cell lines of monoclonal anti-CEA antibody-saporin immunotoxin.
por: Manosroi, J., et al.
Publicado: (1992)

Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.
por: Marshall, D., et al.
Publicado: (1996)

The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.
por: Mitchell, H., et al.
Publicado: (1980)

Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
por: Rowlinson-Busza, G., et al.
Publicado: (1995)

In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
por: Blumenthal, R D, et al.
Publicado: (2008)

Regulation of cytochrome P450 gene expression in human colon and breast tumour xenografts.
por: Smith, G., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_q2k7pcngu0gdeadb9tfco9b5up